Retinoic acid activates human inducible nitric oxide synthase gene through binding of RARα/RXRα heterodimer to a novel retinoic acid response element in the promoter

Biochemical and Biophysical Research Communications

Volumn 355, Issue 2, 2007, Pages 494-500

  Zou, Fang ^a   Liu, Yan ^a   Liu, Li ^a   Wu, Kailang ^a   Wei, Wei ^a   Zhu, Ying ^a   Wu, Jianguo ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Heterodimer; hiNOS; RAR ; RARE; RXR

Indexed keywords

HETERODIMER; INDUCIBLE NITRIC OXIDE SYNTHASE; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOID X RECEPTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENZYME INDUCTION; ENZYME REGULATION; GENE ACTIVATION; GENE DELETION; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS;

BASE SEQUENCE; DIMERIZATION; DNA PRIMERS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HELA CELLS; HUMANS; NITRIC OXIDE SYNTHASE TYPE II; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RNA, MESSENGER; TRETINOIN;

EID: 33847126958     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.01.178     Document Type: Article

References (28)

1. Lala P.K., and Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 3 (2001) 149-156
2. Xie K., Huang S., Dong Z., et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181 (1995) 1333-1343
3. Xie K., Dong Z., and Fidler I.J. Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J. Leukoc. Biol. 59 (1996) 797-803
4. Juang S.H., Xie K., Xu L., et al. Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene. Hum. Gene Ther. 9 (1998) 845-854
5. Xu W., Liu L., and Charles I.G. Microencapsulated iNOS-expressing cells cause tumor suppression in mice. FASEB J. 16 (2002) 213-215
6. Chan E.D., and Riches D.W. IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. Am. J. Physiol. Cell Physiol. 280 (2001) C441-C450
7. Nathan C., and Xie Q.W. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269 (1994) 13725-13728
8. Freemantle S.J., Spinella M.J., and Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22 (2003) 7305-7315
9. Mangelsdorf D.J., Thummel C., Beato M., et al. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
10. Heyman R.A., Mangelsdorf D.J., Dyck J.A., et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68 (1992) 397-406
11. Denson L.A., Auld K.L., Schiek D.S., et al. Interleukin-1beta suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J. Biol. Chem. 275 (2000) 8835-8843
12. Jansa P., and Forejt J. A novel type of retinoic acid response element in the second intron of the mouse H2Kb gene is activated by the RAR/RXR heterodimer. Nucleic Acids Res. 24 (1996) 694-701
13. Astrom A., Pettersson U., Chambon P., et al. Retinoic acid induction of human cellular retinoic acid-binding protein-II gene transcription is mediated by retinoic acid receptor-retinoid X receptor heterodimers bound to one far upstream retinoic acid-responsive element with 5-base pair spacing. J. Biol. Chem. 269 (1994) 22334-22339
14. Giguere V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr. Rev. 15 (1994) 61-79
15. Califano J., van der Riet P., Westra W., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 56 (1996) 2488-2492
16. Crowe D.L., and Chandraratna R.A. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands. Breast Cancer Res. 6 (2004) R546-R555
17. Okuno M., Kojima S., Matsushima-Nishiwaki R., et al. Retinoids in cancer chemoprevention. Curr. Cancer Drug Targets 4 (2004) 285-298
18. Seguin-Devaux C., Devaux Y., Latger-Cannard V., et al. Enhancement of the inducible NO synthase activation by retinoic acid is mimicked by RARalpha agonist in vivo. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E525-E535
19. Devaux Y., Grosjean S., Seguin C., et al. Retinoic acid and host-pathogen interactions: effects on inducible nitric oxide synthase in vivo. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E1045-E1053
20. Uchimura K., Nakamuta M., Enjoji M., et al. Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat kupffer cells. Hepatology 33 (2001) 91-99
21. J. Sambrook, D.W. Russell (Eds.), Site-Specific Mutagenesis by Overlap Extension, Molecular Cloning: A Laboratory Manual, third ed., Cold Spring Harbor Laboratory Press, New York, 2001, chapter 13 protocol 6.
22. Marone M., Mozzetti S., De Ritis D., et al. Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample. Biol. Proced. Online 3 (2001) 19-25
23. Kim Y., and Fischer S.M. Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues. J. Biol. Chem. 273 (1998) 27686-27694
24. Abrams K.L., Xu J., Nativelle-Serpentini C., et al. An evolutionary and molecular analysis of Bmp2 expression. J. Biol. Chem. 279 (2004) 15916-15928
25. Taylor B.S., de Vera M.E., Ganster R.W., et al. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase Gene. J. Biol. Chem. 273 (1998) 15148-15156
26. Darville M.I., and Eizirik D.L. Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-kB and C/EBP. Diabetes 50 (2001) 741-1748
27. Marks-Konczalik J., Chu S.C., and Moss J. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding Sites. J. Biol. Chem. 273 (1998) 22201-22208
28. Thacher S.M., Vasudevan J., and Chandraratna R.A. Therapeutic applications for ligands of retinoid receptors. Curr. Pharm. Des. 6 (2000) 25-58